Sign In
Buy HRTX
$0.447
-0.0032 (-0.711%)
At Close: Jun 03, 2026
The Daily Biotech Pulse: Chiasma, Heron Await FDA Decisions, DBV Restructures, 3 Biopharmas Make Wall Street Debuts
12:28pm, Friday, 26'th Jun 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 25) * Brainstorm Cell Therapeutics Inc (NASDAQ: BCLI) *
Alliancebernstein L.P. Has $3.06 Million Holdings in Heron Therapeutics Inc (NASDAQ:HRTX)
05:34am, Friday, 26'th Jun 2020
Alliancebernstein L.P. grew its holdings in Heron Therapeutics Inc (NASDAQ:HRTX) by 107.5% during the first quarter, Holdings Channel.com reports. The firm owned 260,630 shares of the biotechnology co
The Daily Biotech Pulse: Chiasma, Heron Await FDA Decisions, DBV Restructures, 3 Biopharmas Make Wall Street Debuts
12:00am, Friday, 26'th Jun 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 25)
Brainstorm Cell...
Heron Therapeutics Inc (NASDAQ:HRTX) Shares Purchased by Baird Financial Group Inc.
06:42am, Wednesday, 24'th Jun 2020
Baird Financial Group Inc. raised its stake in Heron Therapeutics Inc (NASDAQ:HRTX) by 22.8% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exch
Here is What Hedge Funds Think About Heron Therapeutics Inc (HRTX)
11:51pm, Tuesday, 23'rd Jun 2020
In this article you are going to find out whether hedge funds think Heron Therapeutics Inc (NASDAQ:HRTX) is a good investment right now. We like to check what the smart money thinks first before doing
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Heron Therapeutics
Two Sigma Investments LP Sells 17,757 Shares of Heron Therapeutics Inc (NASDAQ:HRTX)
08:02am, Monday, 22'nd Jun 2020
Two Sigma Investments LP cut its stake in shares of Heron Therapeutics Inc (NASDAQ:HRTX) by 13.3% in the first quarter, according to the company in its most recent filing with the Securities and Excha
The Week Ahead In Biotech: Karyopharm, Zogenix, Heron, Chiasma On The Radar Ahead Of FDA Decisions
06:53pm, Sunday, 21'st Jun 2020
Biotech stocks rebounded along with the broader market in the week ended June 19. The week was a busy one from the perspective of PDUFA dates, with the FDA issuing approvals for Merck & Co., Inc. (NYS
The Week Ahead In Biotech: Karyopharm, Zogenix, Heron, Chiasma On The Radar Ahead Of FDA Decisions
12:00am, Sunday, 21'st Jun 2020
Biotech stocks rebounded along with the broader market in the week ended June 19. The week was a busy one from the perspective of PDUFA dates, with the FDA issuing approvals...
Stocks To Watch: Nike, Apple, Ford And Stressed Banks
08:39am, Saturday, 20'th Jun 2020
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive th
2 Top Healthcare Stocks to Watch in June | The Motley Fool
02:00pm, Tuesday, 16'th Jun 2020
Heron Therapeutics and Novavax are two key healthcare stocks to watch this month.
BNP Paribas Arbitrage SA Increases Stock Position in Heron Therapeutics Inc (NASDAQ:HRTX)
07:04am, Sunday, 14'th Jun 2020
BNP Paribas Arbitrage SA boosted its stake in Heron Therapeutics Inc (NASDAQ:HRTX) by 782.5% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchan
Heron Therpeutics Highlights Publication Of Results From Phase 2b Study Of HTX-011 In Patients Undergoing Total Knee Arthroplasty
01:14pm, Thursday, 04'th Jun 2020
Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most importan
Attention Biotech Investors: Mark Your Calendar For June PDUFA Dates
12:00am, Monday, 01'st Jun 2020
Despite the FDA tied up with COVID-19-related activities, May turned out to be a positive month for biopharma companies from the perspective of drug approvals. Three new molecular...
